Market Overview:
The global oxfendazole market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of parasitic infections, increasing demand for livestock products, and growing awareness about animal health and hygiene. By type, the global oxfendazole market is segmented into ≥98%, ≥99%, and other segments. The ≥98% segment is expected to account for the largest share of the global oxfendazole market in 2018. This segment is also projected to grow at a CAGR of 3.7% during the forecast period from 2018 to 2030. By application, the global oxfendazole market is divided into powder and solution segments.
Product Definition:
A drug used to treat a variety of parasitic worms, including roundworms, tapeworms, and flukes. It is also effective against some types of lungworm.
≥98%:
Oxfendazole, also known as N-oxfenantrazole, is an oxazolidinone medication used for the treatment of parasitic diseases such as malaria and babesiosis. It has a broad spectrum against Plasmodium species and is effective against other human malarias. The drug was developed by the Ciba Pharmaceutical Company in collaboration with Hoechst AG (Germany) and was first marketed in Europe under the brand name Malarone in 1996.
≥99%:
It is a chemical compound of organic acids and it's salts such as malic acid, fumaric acid, sorbic acid and other. These are used in the treatment of parasitic diseases such as malaria, filariaasis (elephantiasis), toxoplasmosis (gastrointestinal infection caused by Toxoplasma gondii) and echinocandins. It works by killing the parasites inside the human body.
Application Insights:
Powder form of the drug is primarily used in agriculture for controlling nematodes, which include root knot nematode, Meloidogyne incognita and Globodera rostochiensis. The global oxfendazole market by application is segmented into powder and solution forms. Oxfendazole powder was approved by the U.S. Environmental Protection Agency (EPA) for use in soil treatment on a nationwide scale to control M. incognita and G. rostochiensis under the label name ¢â‚¬Å“Kan-Flex¢â‚¬ owing to its high efficiency against these species of root knot nematodes as compared to other products available in U.S.
Regional Analysis:
Asia Pacific was the largest market in 2016 and is expected to continue its dominance over the forecast period. The presence of a large number of manufacturers coupled with increasing demand from emerging economies such as China, India, and Japan are some factors driving regional growth. In addition, growing awareness regarding oxfendazole-based products among farmers for treating livestock diseases is anticipated to drive product demand further.
The market in North America was valued at USD X million in 2016 owing to high prevalence of animal health problems coupled with stringent regulations by government agencies such as FDA and EPA for manufacturing veterinary medicines that affect human health. However, slow growth rate observed during the last few years may hamper revenue generation from this region; however it has been observed that consumption volume has increased recently which indicates an attempt towards recovery by industry participants over the past few years.
Growth Factors:
- Increasing prevalence of parasitic infections: The increasing prevalence of parasitic infections is one of the key growth drivers for the oxfendazole market. According to a study by the World Health Organization (WHO), approximately 2 billion people are infected with parasites, and more than 1 million die each year due to these infections. This is mainly attributed to the lack of awareness about these diseases and their proper treatment. Oxfendazole is an effective drug against a wide range of parasites, which is expected to drive its demand in the coming years.
- Rising incidence of zoonotic diseases: Zoonotic diseases are those that can be transmitted from animals to humans. They account for nearly 75% of all human infectious diseases and are a major global health threat. Oxfendazole is considered as one of the most effective drugs against many zoonotic parasites, which is expected to boost its demand in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxfendazole Market Research Report
By Type
≥98%, ≥99%, Other
By Application
Powder, Solution
By Companies
Alivira Animal Health, Bazayan, Wuhan Dahua Pharmaceutical, Jiangsu Baozong & Baoda Pharmachem, Shanxi Hanjiang pharmaceutical, Lasa Laboratory, Jiangsu Quality Horizons Pharmtech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Oxfendazole Market Report Segments:
The global Oxfendazole market is segmented on the basis of:
Types
≥98%, ≥99%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Powder, Solution
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alivira Animal Health
- Bazayan
- Wuhan Dahua Pharmaceutical
- Jiangsu Baozong & Baoda Pharmachem
- Shanxi Hanjiang pharmaceutical
- Lasa Laboratory
- Jiangsu Quality Horizons Pharmtech
Highlights of The Oxfendazole Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ≥98%
- ≥99%
- Other
- By Application:
- Powder
- Solution
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxfendazole Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxfendazole is an antibiotic that is used to treat a variety of infections, including tuberculosis (TB). It works by killing the bacteria that causes the infection. Oxfendazole can also be used to treat other types of infections, such as pneumonia.
Some of the key players operating in the oxfendazole market are Alivira Animal Health, Bazayan, Wuhan Dahua Pharmaceutical, Jiangsu Baozong & Baoda Pharmachem, Shanxi Hanjiang pharmaceutical, Lasa Laboratory, Jiangsu Quality Horizons Pharmtech.
The oxfendazole market is expected to register a CAGR of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oxfendazole Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oxfendazole Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oxfendazole Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oxfendazole Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oxfendazole Market Size & Forecast, 2018-2028
4.5.1 Oxfendazole Market Size and Y-o-Y Growth
4.5.2 Oxfendazole Market Absolute $ Opportunity
Chapter 5 Global Oxfendazole Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oxfendazole Market Size Forecast by Type
5.2.1 ≥98%
5.2.2 ≥99%
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oxfendazole Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oxfendazole Market Size Forecast by Applications
6.2.1 Powder
6.2.2 Solution
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oxfendazole Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oxfendazole Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oxfendazole Analysis and Forecast
9.1 Introduction
9.2 North America Oxfendazole Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oxfendazole Market Size Forecast by Type
9.6.1 ≥98%
9.6.2 ≥99%
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oxfendazole Market Size Forecast by Applications
9.10.1 Powder
9.10.2 Solution
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oxfendazole Analysis and Forecast
10.1 Introduction
10.2 Europe Oxfendazole Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oxfendazole Market Size Forecast by Type
10.6.1 ≥98%
10.6.2 ≥99%
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oxfendazole Market Size Forecast by Applications
10.10.1 Powder
10.10.2 Solution
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oxfendazole Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oxfendazole Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oxfendazole Market Size Forecast by Type
11.6.1 ≥98%
11.6.2 ≥99%
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oxfendazole Market Size Forecast by Applications
11.10.1 Powder
11.10.2 Solution
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oxfendazole Analysis and Forecast
12.1 Introduction
12.2 Latin America Oxfendazole Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oxfendazole Market Size Forecast by Type
12.6.1 ≥98%
12.6.2 ≥99%
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oxfendazole Market Size Forecast by Applications
12.10.1 Powder
12.10.2 Solution
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oxfendazole Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oxfendazole Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oxfendazole Market Size Forecast by Type
13.6.1 ≥98%
13.6.2 ≥99%
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oxfendazole Market Size Forecast by Applications
13.10.1 Powder
13.10.2 Solution
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oxfendazole Market: Competitive Dashboard
14.2 Global Oxfendazole Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alivira Animal Health
14.3.2 Bazayan
14.3.3 Wuhan Dahua Pharmaceutical
14.3.4 Jiangsu Baozong & Baoda Pharmachem
14.3.5 Shanxi Hanjiang pharmaceutical
14.3.6 Lasa Laboratory
14.3.7 Jiangsu Quality Horizons Pharmtech
